• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿路上皮蛋白 IIIa 是膀胱癌的标志物,但似乎不能反映化学致癌作用。

Uroplakin IIIa Is a Marker in Bladder Cancer but Seems Not to Reflect Chemical Carcinogenesis.

机构信息

Department of Toxicology, Wroclaw Medical University, Wroclaw, Poland.

Department of Urology and Oncological Urology, Wroclaw Medical University, Wroclaw, Poland.

出版信息

Biomed Res Int. 2018 Jul 5;2018:8315410. doi: 10.1155/2018/8315410. eCollection 2018.

DOI:10.1155/2018/8315410
PMID:30069482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6057425/
Abstract

BACKGROUND

Uroplakins are glycoproteins investigated as potential markers of urothelial carcinoma. However, their role in chemical carcinogenesis is uncertain. In this study the diagnostic value of plasma and urine uroplakin IIIa (UPIIIa) levels in bladder cancer (BC) was investigated, particularly in the aspect of environmental exposure to chemical carcinogens, measured by DNA damage and detoxification ability in the BC smoking group. The correlation between uroplakin, 8-OHdG, and GST was investigated.

MATERIAL AND METHODS

This study included 61 BC patients and 33 healthy controls. UPIIIa, 8-OHdG, and GST levels were estimated by the immunoenzymatic method (ELISA).

RESULTS

UPIIIa levels were elevated in BC patients in plasma (p≤0.001) and in urine (p≤0.001), as were 8-OHdG and GST levels in urine. Moreover, the 8-OHdG level was higher in invasive or high grade tumors. A positive correlation between UPIIIa/GST and 8-OHdG/GST was observed, but no UPIIIa/8-OHdG correlation was noted.

CONCLUSION

The study showed the diagnostic value of urine and plasma UPIIIa in BC (good sensitivity, specificity, and predictive value). The lack of UPIIIa correlation with 8-OHdG and smoking suggests that UPIIIa does not reflect the environmental exposure. The increased levels of 8-OHdG and GST in the invasive tumor stage indicate their value in BC monitoring.

摘要

背景

尿路上皮蛋白被认为是潜在的膀胱癌标志物。然而,其在化学致癌作用中的作用尚不清楚。本研究旨在探讨尿路上皮蛋白 IIIa(UPIIIa)在膀胱癌(BC)患者血浆和尿液中的诊断价值,特别是在 BC 吸烟组中,通过 DNA 损伤和解毒能力来检测环境中化学致癌物的暴露情况。同时还研究了尿路上皮蛋白与 8-OHdG 和 GST 的相关性。

材料和方法

本研究共纳入 61 例 BC 患者和 33 例健康对照者。采用酶联免疫吸附试验(ELISA)检测 UPIIIa、8-OHdG 和 GST 水平。

结果

BC 患者血浆和尿液中 UPIIIa 水平均升高(p≤0.001),尿液中 8-OHdG 和 GST 水平也升高。此外,侵袭性或高级别肿瘤患者的 8-OHdG 水平更高。UPIIIa/GST 与 8-OHdG/GST 之间呈正相关,但 UPIIIa 与 8-OHdG 之间无相关性。

结论

本研究表明尿液和血浆 UPIIIa 对 BC 具有诊断价值(具有良好的敏感性、特异性和预测价值)。UPIIIa 与 8-OHdG 和吸烟之间缺乏相关性提示其不能反映环境暴露情况。侵袭性肿瘤阶段 8-OHdG 和 GST 水平的升高表明其在 BC 监测中的价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c47/6057425/aac05e97ae92/BMRI2018-8315410.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c47/6057425/fb8b79ffcaa8/BMRI2018-8315410.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c47/6057425/aac05e97ae92/BMRI2018-8315410.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c47/6057425/fb8b79ffcaa8/BMRI2018-8315410.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c47/6057425/aac05e97ae92/BMRI2018-8315410.002.jpg

相似文献

1
Uroplakin IIIa Is a Marker in Bladder Cancer but Seems Not to Reflect Chemical Carcinogenesis.尿路上皮蛋白 IIIa 是膀胱癌的标志物,但似乎不能反映化学致癌作用。
Biomed Res Int. 2018 Jul 5;2018:8315410. doi: 10.1155/2018/8315410. eCollection 2018.
2
[Assessment of 8-hydroxy-2'-deoxyguanosine concentrations in bladder cancer patients treated with intravesical BCG instillation].[膀胱内灌注卡介苗治疗的膀胱癌患者8-羟基-2'-脱氧鸟苷浓度的评估]
Pol Merkur Lekarski. 2005 Oct;19(112):526-8.
3
Initial Evaluation of Uroplakins UPIIIa and UPII in Selected Benign Urological Diseases.尿路上皮多态蛋白 IIIa 和 II 在选定的良性泌尿科疾病中的初步评估。
Biomolecules. 2021 Dec 2;11(12):1816. doi: 10.3390/biom11121816.
4
Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer.尿路上皮蛋白 2 用于膀胱癌诊断效用的初步评估及其对患者抗氧化潜能的评估。
Biomed Res Int. 2018 Nov 29;2018:8693297. doi: 10.1155/2018/8693297. eCollection 2018.
5
The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens.核基质蛋白在膀胱癌中关于致癌物环境风险方面的诊断价值
Biomed Res Int. 2017;2017:9643139. doi: 10.1155/2017/9643139. Epub 2017 Aug 8.
6
8-Hydroxy-2'-deoxyguanosine as a Discriminatory Biomarker for Early Detection of Breast Cancer.8-羟基-2'-脱氧鸟苷作为乳腺癌早期检测的鉴别性生物标志物。
Clin Breast Cancer. 2019 Apr;19(2):e385-e393. doi: 10.1016/j.clbc.2018.12.013. Epub 2018 Dec 21.
7
GSTM1 and APE1 genotypes affect arsenic-induced oxidative stress: a repeated measures study.谷胱甘肽硫转移酶M1和脱嘌呤嘧啶核酸内切酶1基因多态性影响砷诱导的氧化应激:一项重复测量研究
Environ Health. 2007 Dec 4;6:39. doi: 10.1186/1476-069X-6-39.
8
High expression level of preoperative serum Uroplakin III is associated with biologically aggressive bladder cancer.术前血清uroplakin III的高表达水平与具有生物学侵袭性的膀胱癌相关。
Asian Pac J Cancer Prev. 2015;16(4):1539-43. doi: 10.7314/apjcp.2015.16.4.1539.
9
Alterations in bladder function associated with urothelial defects in uroplakin II and IIIa knockout mice.Uroplakin II 和 IIIa 基因敲除小鼠的尿路上皮缺陷相关的膀胱功能改变。
Neurourol Urodyn. 2009;28(8):1028-33. doi: 10.1002/nau.20688.
10
Altered expression of UPIa, UPIb, UPII, and UPIIIa during urothelial carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.UPIa、UPIb、UPII 和 UPIIIa 在 N-丁基-N-(4-羟丁基)亚硝胺诱导大鼠尿路上皮癌发生过程中的表达改变。
Virchows Arch. 2011 May;458(5):603-13. doi: 10.1007/s00428-011-1045-6. Epub 2011 Feb 8.

引用本文的文献

1
Initial Evaluation of Uroplakins UPIIIa and UPII in Selected Benign Urological Diseases.尿路上皮多态蛋白 IIIa 和 II 在选定的良性泌尿科疾病中的初步评估。
Biomolecules. 2021 Dec 2;11(12):1816. doi: 10.3390/biom11121816.
2
Preliminary Evaluation of the Diagnostic Usefulness of Uroplakin 2 with an Assessment of the Antioxidant Potential of Patients with Bladder Cancer.尿路上皮蛋白 2 用于膀胱癌诊断效用的初步评估及其对患者抗氧化潜能的评估。
Biomed Res Int. 2018 Nov 29;2018:8693297. doi: 10.1155/2018/8693297. eCollection 2018.

本文引用的文献

1
Evaluation of NMP22 in bladder cancer patients sensitive to environmental toxins.对环境毒素敏感的膀胱癌患者中NMP22的评估。
Adv Clin Exp Med. 2017 Oct;26(7):1069-1075. doi: 10.17219/acem/63156.
2
The Diagnostic Value of Nuclear Matrix Proteins in Bladder Cancer in the Aspect of Environmental Risk from Carcinogens.核基质蛋白在膀胱癌中关于致癌物环境风险方面的诊断价值
Biomed Res Int. 2017;2017:9643139. doi: 10.1155/2017/9643139. Epub 2017 Aug 8.
3
Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma.
用于诊断移行性膀胱癌的高灵敏度和高特异性新型生物标志物。
Oncotarget. 2015 May 30;6(15):13539-49. doi: 10.18632/oncotarget.3841.
4
High expression level of preoperative serum Uroplakin III is associated with biologically aggressive bladder cancer.术前血清uroplakin III的高表达水平与具有生物学侵袭性的膀胱癌相关。
Asian Pac J Cancer Prev. 2015;16(4):1539-43. doi: 10.7314/apjcp.2015.16.4.1539.
5
Uroplakins do not restrict CO2 transport through urothelium.尿路上皮层素不会限制二氧化碳通过尿路上皮的运输。
J Biol Chem. 2012 Mar 30;287(14):11011-7. doi: 10.1074/jbc.M112.339283. Epub 2012 Feb 7.
6
Oxidative DNA damage estimated by urinary 8-hydroxy-2'-deoxyguanosine and arsenic in glass production workers.通过尿中8-羟基-2'-脱氧鸟苷评估玻璃生产工人的氧化DNA损伤及砷暴露情况
Toxicol Ind Health. 2012 Jul;28(6):513-21. doi: 10.1177/0748233711416945. Epub 2011 Oct 27.
7
8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma.8-羟基脱氧鸟苷和硝基酪氨酸是膀胱癌的预后因素。
Int J Clin Exp Pathol. 2011 Mar;4(3):267-75. Epub 2011 Mar 2.
8
[Diagnostic test for bladder cancer: the NMP22®].
Prog Urol. 2011 Apr;21(4):245-9. doi: 10.1016/j.purol.2010.09.027. Epub 2011 Jan 7.
9
Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury.尿液生物标志物在急性肾损伤的临床预后和早期检测中的应用。
Clin J Am Soc Nephrol. 2010 Dec;5(12):2154-65. doi: 10.2215/CJN.00740110. Epub 2010 Aug 26.
10
UPK3A: a promising novel urinary marker for the detection of bladder cancer.UPK3A:一种有前途的新型尿生物标志物,可用于膀胱癌的检测。
Urology. 2010 Aug;76(2):514.e6-11. doi: 10.1016/j.urology.2009.11.045. Epub 2010 Mar 25.